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Recent advancements in medicine, ranging from transplant surgery to 
in vitro fertilisation, nanotechnology and neuroscience, have drastically 
changed the way in which human bodies are perceived. There are 
abundant examples in law showing the law’s uneasiness in making 
sense of the human body in the context of ownership and property, as 
the notion of owning oneself (and one’s tissues) implies that persons 
are able to objectify their selves, and in the process become susceptible 
to objectification by others. The question of the human body as 
property involves complex and philosophical dimensions which cannot 
be comprehensively discussed in the scope of this article.
The human body and its parts are traditionally classified as res 
extra commercium (things outside the commercial sphere). Separated 
bodily materials present another problematical category, as the law 
has traditionally regarded separated bodily materials as res nullius, 
belonging to no one, until brought under the control of the first 
person who obtains possession of the separated human tissue.[1]
The universal legal prohibition on the sale or trade of human tissue, 
embodied globally, and various statutory regulations on the use of 
human tissue are equally ambiguous, as these statutory prohibitions 
paradoxically reinforce a construction of the human body as a 
commodity (property), subject to regulation.[1]
This prompts the question as to how, in view of the common law 
position that no man is dominus membrorum suorum (master of his 
own bodily members) and the universal notion that the human body 
is res extra commercium (a thing outside the commercial sphere), [2] 
legislation in South Africa addresses the issue of human tissue as 
property, and, if it does hold this view, what the consequences of 
this classification are. What rights do individuals have over their own 
tissues, if any? As South Africa is becoming an increasingly litigious 
environment, a legal analysis of the classification of human tissue is 
extremely relevant.
National Health Act 61 of 2003 and 
relevant regulations
The National Health Act (NHA)[3] defines tissue as ‘…human tissue, 
and includes flesh, bone, a gland, an organ, skin, bone marrow or body 
fluid, but excludes blood or a gamete.’  The 2012 Regulations Relating 
to the Use of Human Biological Material[4] define biological material 
as ‘… material from a human being including DNA, RNA, blastomeres, 
polar bodies, cultured cells, embryos, gametes, progenitor stem cells, 
small tissue biopsies and growth factors from the same.’ Furthermore, 
the 2012 Regulations Relating to Tissue Banks[5] define tissue as ‘… a 
functional group of cells. The term is used collectively in Regulations to 
indicate both cells and tissue.’ Finally, the Regulations Relating to the 
Import and Export of Human Tissue, Blood, Blood products, Cultured 
Cells, Stem Cells, Embryos, Foetal Tissue, Zygotes and Gametes[6] 
define a substance as ‘…  tissue, blood, blood product or gamete’.The 
Regulations Regarding Rendering of Clinical Forensic Medicine 
Services[7] define a body specimen as ‘…anybody [sic] sample which can 
be tested to determine the presence or absence of HIV infection.’
The contradictions between the definitions are evident, and as they 
currently stand the definitions result in ambiguity. The NHA definition 
of tissues exclude gametes, while the definition of biological material 
in the Regulations Relating to the Use of Human Biological Material 
includes material from a human being (which includes tissues) and 
gametes. However, the definition as per the Regulations Relating 
to Tissue Banks indicates that ‘tissue’ is used collectively to indicate 
both cells and tissues. In addition to the obvious contradictions, the 
definitions in the NHA and the Regulations thereto do not provide for 
a legal classification of human tissue. This leaves questions about the 
classification of human tissue open-ended.
Regulations 2(a) and 2(b) of the Regulations Relating to the Use of 
Human Biological Material allow for the removal of biological material 
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(including tissues) for genetic testing, genetic training, genetic health 
research or therapeutic purposes by a competent person and at an 
authorised, prescribed institution. The definition of a competent 
person describes who may be authorised to remove certain tissues 
for specific processes. Furthermore, these Regulations[4] specify that 
human biological material, may be removed or withdrawn from living 
persons for the following medical and dental purposes:
• DNA, RNA and chromosome-based genetic testing
• health research referred to in section 69(3) of the NHA
• training referred to in section 64(1)(a) of the NHA
• studies of archaeological, medical or heritage value on DNA 
obtained from human genetic material, conducted in terms of 
the National Heritage Resources Act.
Regulation 3 of the Regulations relating to the Use of Human 
Biological Material provides that a competent person may not remove 
any biological material from the body of another living person for the 
purpose of genetic testing, genetic training, genetic health research 
or therapeutics unless it is done:
• with the written informed consent of the person from whom 
such biological material shall be removed
• with the written informed consent of a child over the age of 12 
years, provided that child has sufficient maturity and the mental 
capacity to understand the benefits, risks and social implications 
of the procedure (should the child not possess sufficient maturity 
or understanding, the written informed consent of the parent or 
guardian will be necessary)
• with the written informed consent of a parent, guardian or 
caregiver where the child is younger than 12 years
• consent by the head of a health establishment in the case of an 
emergency
• consent by the Minister, if the parent, guardian or caregiver of 
the child unreasonably refuses or is incapable of giving consent, 
cannot be readily traced or is deceased
• with the written informed consent of a mentally ill person if that 
person is capable of giving consent; or a curator, spouse, next 
of kin, a parent, guardian, major child, brother or sister, partner 
or associate, if such mentally ill person is incapable of giving 
consent; and the head of a health establishment in the case of 
an emergency.
Regulations 4(1) and 4(2) of the Regulations Relating to the Use of 
Human Biological Material provide that any organisation, institution 
or person that intends to use tissue from a deceased person for 
purposes of genetic testing, health research and therapeutics, 
where no consent has been given by the deceased person before 
his or her death and where there is no evidence that the removal 
of the tissue or cells would be contrary to a direction given by the 
deceased before his or her death, must take steps to locate the 
spouse, partner, major child, parent, guardian, major brother or 
major sister of a deceased person, in the specific order mentioned, 
in order to obtain consent.
A foreign case which is currently dealing with the removal of 
tissue from deceased persons without informed consent is that of 
the Ivano-Frankovsk regional morgue in western Ukraine, where it 
is alleged that parts from 56 human corpses were improperly fed 
into the international tissue market.[8] In 2012, charges were filed 
against the morgue’s deputy director, three coroners and a nurse 
alleging that they deceived families into signing consent forms and 
that they did not get proper permission before tissue was obtained 
from corpses. [8] These latest criminal charges in Ukraine follow an 
investigation published in July by the International Consortium of 
Investigative Journalists (ICIJ). The ICIJ probe revealed legal, ethical 
and medical concerns surrounding the growing for-profit human 
tissue industry. Families told the ICIJ that their relatives’ cadavers were 
harvested without informed consent. 
The case in Ivano-Frankovsk is one of five cases in which questions 
have been raised about whether Ukrainian morgues that supplied 
tissue to the international market were taking tissue without consent. 
Prosecutors indicated that the defendants face up to 7 years in prison 
if found guilty.[8]
Although South African legislation seems to adequately deal 
with the issue of informed consent for the removal of human 
biological material from living and deceased persons for research/
study purposes, informed consent relating to the participation in the 
research/study should be distinguished from specific consent relating 
to the future use of human biological material. This is an issue that is 
often overlooked. 
Despite the existence of international research ethics documents 
and conventions governing the future use of human biological 
material,[9-12] as Nienaber[13] points out, South Africa’s framework does 
not address informed consent for the future use of human biological 
material, unlike other African countries like Nigeria and Kenya. The 
question then arises as to what the fate is of human tissue after it has 
been procured for research purposes. Does it become the property 
of the institution to which it has been given? Does the research 
institution own the research subject’s tissues?
Ownership of human tissue
The ownership of tissue samples donated for medical research 
is an ongoing subject of dispute. Some advocates assert that 
patients have ongoing ownership rights in their tissues, including 
an unfettered right to determine what happens to their tissue 
sample. [14] Researchers argue that giving patients property rights 
in their samples will turn the human body and body parts into a 
commodity and bring research to a halt.[14] One thing is certain: 
the creation of commercial products from human tissue has 
generated very difficult legal and ethical questions that have 
no clear, universally accepted answers. When those questions 
have come up in litigation, the courts have struggled to adapt 
the tradition and precedent of the law to the challenges arising 
from the biotechnology era. The case of Washington University v. 
Catalona is the most recent instance of a court seeking to resolve 
this dilemma.[14]
The case involves a former Washington University surgeon, William 
Catalona, MD, who was engaged in research using the prostate 
cancer repository. Dr Catalona had argued unsuccessfully in the 
lower courts that research participants who donated tissue and 
blood samples to the university for prostate cancer research could 
require the university to transfer their tissues to him at his new place 
of employment.[15] The Court upheld a unanimous 2007 ruling by the 
Eighth US Circuit Court of Appeals that stated prostate tissue and 
serum samples donated to Washington University may continue to 
be used by the institution for cancer research.
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The appellate court had affirmed the lower federal district court 
ruling that donors who gave tissue or serum samples to the university 
for research cannot later compel the school to transfer ownership of 
the samples to another research institution. The Court held that under 
the specific facts of the case, the men who participated had donated 
their tissue to the university as a gift and they could not get it back or 
have it sent to another researcher. However, the Eighth Circuit Court 
indicated that the men retained the right to stop participating in the 
research by:
• declining to answer any additional questions
• not donating more tissue, or
• disallowing the use of their tissue in future research.
This means that the men have the right to order the university to stop 
using their tissue, and the university cannot merely strip their names 
off it and continue to use it as they please.
Understanding ownership
The common-law description of ownership is found in South African 
case law, where ownership is defined in various decisions as ‘the 
most complete real right which gives the owner the most complete and 
absolute entitlements to a thing. Even so, it is a right which can be limited 
by objective law and by the rights of others (limited real rights or creditor’s 
rights).’[16] A thing is defined ‘in terms of characteristics, as a corporeal 
or tangible object external to persons and which is, as an independent 
entity, subject to juridical control by a legal subject, to whom it is useful 
and of value.’[16]
Ownership is a real right that is often defined on the basis of 
entitlements. The following entitlements are usually distinguished: 
control; use; encumber (the entitlement to grant limited real rights 
in respect of a thing); alienate/transfer; and vindicate (the unique 
entitlement of the owner to claim the thing from another person).[16]
Should an institution or organisation procure ownership of an 
individual’s tissues, it would obtain a real right and ultimate control 
over that tissue. This could result in unscrupulous individuals utilising 
tissues of vulnerable individuals to advance the purposes of their 
research, without consideration of the individuals from whom the 
tissues were sought. Furthermore, should the research institutions 
‘own’ tissues by a transfer of ownership rights from the research 
subject to the specific institution, any future uses of the tissues 
may occur without the research subject’s consent. In this scenario, 
since ownership rights have been transferred to the institution, any 
proceeds generated from a therapy produced using the individual’s 
tissues (directly or indirectly), may never benefit the individual in 
question.
In Moore v Regents of the University of California, the physician 
treating Mr Moore for hairy-cell leukaemia in 1976 removed samples 
of his blood, bone marrow aspirate and other tissues and fluid for 
examination.[17] The physician and his research assistant knew upon 
taking these samples that the tissues had potential commercial 
and scientific value as material for medical research, but they did 
not disclose this information to Moore.[17] In 1979, the University of 
California, Los Angeles (UCLA) Medical Center researchers established 
and patented a cell line from Moore’s cells. The patent was assigned to 
the Regents of the University of California (Regents) who assisted the 
researchers in commercial development of the cell line and products 
to be developed from it. When Moore discovered that his cells had 
been used in developing the patent, he took legal action against 
Regents and the UCLA Medical Centre researchers and doctors 
involved in his care.
The California Supreme Court found that Moore had a cause of 
action for breach of his physician’s disclosure obligations and that 
an individual has a tangible property right in his or her own tissue. [18] 
In dicta, however, the court explicitly stated that its decision left 
undecided whether the transfer of human tissue should be gift-based 
or market-based, and that future controversies would have to be 
decided on a case-by- case basis.[18]
Recommendations and lessons learnt 
from these foreign case-law examples
When dealing with the issue of ownership of human tissues, there 
are no firm ‘rules’ per se. Each situation will have to be determined by 
the facts presented in that particular case. An individual may have a 
tangible proprietary right or interest in his or her own tissues. Any 
proceeds generated from the use of that individual’s tissue will have 
to be apportioned to the individual himself. However, guidance on 
the exact apportionment of profits has not been explored in South 
African law. Therefore, the practitioner or researcher who intends to 
utilise an individual’s tissue will have to obtain the individual’s prior 
informed consent to do so and inform the individual of their intention 
to do so. This should include a very clear exposition of the intended 
uses of the individual’s tissue, as well as possible profit that may result 
from the use of the tissue.
Truog et al.[19] have suggested that there are three distinct 
obligations that an investigator who seeks access to tissue might 
have towards an individual whose tissues, upon removal from the 
body, might hold value for biomedical research. These include:
• consent 
• compensation for effort and burden
• rights to revenue streams.
While the issues of consent and revenue streams have briefly been 
alluded to in this article, it is generally accepted that subjects 
are compensated for the time, effort (including travel), and co-
operation that their participation requires. It has also been 
suggested that renewable tissues may be procured from volunteers, 
not for their medical benefit, but solely for the benefit of others 
e.g. blood and blood derivatives, oocytes, sperm, and breast milk. 
Truog et al.[19] recommend that, in light of the Moore decision and 
other legal precedents that hold that individuals do not retain 
property ownership over removed tissues, ‘a plausible rationale for 
justifying such payments is that they are made in exchange for the 
performance of a service, rather than for the transfer of property’.[19] 
The question arises however, as to whether such payment for 
renewable tissues is tantamount to organ or tissue trafficking. 
Interestingly, the definition of organ in the NHA[3] is ‘… any part of 
the human body adapted by its structure to perform any particular vital 
function, including the eye and its accessories, but does not include 
skin and appendages, flesh, bone, bone marrow, body fluid, blood 
or a gamete.’ Payment for renewable tissues such as skin, blood or 
gametes would therefore be excluded from organ trafficking.
The NHA Regulations Relating to the Artificial Fertilisation of 
Persons[20] attempt to provide clarity on the issue of ownership and 
state that:
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Before artificial fertilisation, the ownership of a gamete donated 
for the purpose of artificial fertilisation is vested (in the case of a male 
gamete donor) but:
• before receipt of such gamete by the authorised institution to 
effect artificial fertilisation, by the authorised institution which 
removed or withdrew the gamete [our emphasis] 
• after receipt of such gamete by the authorised institution that 
intends to effect artificial fertilisation, in that institution. [our 
emphasis]
In the case of a male gamete donor for the artificial fertilisation of 
his spouse, in that male gamete donor; and in the case of a female 
gamete donor, for the artificial fertilisation of a recipient, in that 
female gamete donor. 
After artificial fertilisation, the ownership of a zygote or embryo 
effected by donation of male and female gametes is vested:
• in the case of a male gamete donor, in the recipient [our 
emphasis]
• in the case of a female donor, in the recipient.[20] [our emphasis]
An embryo is defined in the NHA[3] as ‘… a human offspring in the 
first 8 weeks from conception’ and in the Regulations Relating to the 
Import and Export of Human Tissue, Blood, Blood products, Cultured 
cells, Stem cells, Embryos, Foetal tissue, Zygotes and Gametes[7] as 
‘… a human offspring in the first 8 weeks of conception’. Despite these 
operational definitions (the latter of which is conceptually confusing 
i.e. ‘of conception’), our current legislation does not provide any 
guidance on whether an embryo may fulfil the requirements to be 
categorised as property. Therefore, the exact characterisation of 
an embryo in South African law remains unknown and will have to 
be dealt with on a case-by-case basis, taking into consideration all 
relevant factors. It is submitted that the use of the word ‘ownership’ 
in the NHA Regulations is problematic and that it should have been 
substituted with a ‘proprietary interest’, which denotes something 
different from the legal understanding of ownership.
Proprietary rights are property rights of an owner of proprietary 
information that may be protected under law.[21] Proprietary 
information is information that is not public knowledge. The recipient 
of such information is therefore generally duty bound from making 
unauthorised use of such information.[22] If human tissues are afforded 
a proprietary interest, they would be protected from unauthorised use. 
The holder of the proprietary right (i.e. the research subject) would 
have to consent to any use of their human tissues in the research 
phase and any subsequent future use thereof. This would also ensure 
that the proceeds of any therapy developed from the tissues would be 
distributed, in part, to the subject. 
A mandatory agreement stipulating the terms and conditions 
of such distribution should be required. In this way, unscrupulous 
activities could be minimised and vulnerable individuals, in particular, 
could benefit from the use of their tissues.
In the United Kingdom, separated body parts can, under certain 
circumstances, if skill and labour had been applied thereto, be owned by 
an individual. This view was confirmed in 1998 in R v. Kelly.[23] In this case, a 
technician who worked at the Royal College of Surgeons removed body 
parts and gave these to an artist who used the body parts as moulds to 
create sculptures. Both the technician and the artist were subsequently 
charged with theft. They argued that parts of corpses are not property 
and could therefore not be stolen under the British Theft Act. The Court 
of Appeal held that parts of a corpse are capable of being stolen, if they 
have acquired different attributes by virtue of the application of skill. As 
the body parts in question had been preserved and used as specimens, 
they became fit for proprietary rights.
Conclusion
It is imperative that legislation in South Africa relating to the regulation 
of human tissue be amended to provide a clear and consistent 
message regarding any proprietary claims in respect of human tissue. 
A South African case in point is the recent spate of organ trafficking 
in which medical practitioners at St Augustine’s Hospital performed 
109 illegal operations between 2001 and 2003, which included 
the removal of kidneys from five children, and admitted receiving 
R3.8 million from an illegal organ-trafficking syndicate.[24]
Under the false pretense of ‘further investigations’, a medical 
practitioner or researcher may easily obtain an individual’s tissue without 
the proper required consent. Legal requirements relating to informed 
consent in the South African medico-legal context have been discussed 
extensively.[25] In the context of medical research, specifically Section 
12(2) (c) of the Constitution of the Republic of South Africa, 1996, states 
that everyone has the right to bodily and psychological integrity, which 
includes the right not to be subjected to medical research or scientific 
experiments without his or her informed consent.
In the present context, many academic scientists working in the 
field of human tissues are extremely confused regarding the meaning 
and practical implications of possession, custodianship, ownership, 
database rights and intellectual property generally.[26]  The conflicting 
descriptions in statute and regulations relating to the regulation of 
human tissues, referred to above, add to this confusion. [27]
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